Age Dependence of Breast Cancer

乳腺癌的年龄依赖性

基本信息

  • 批准号:
    8570537
  • 负责人:
  • 金额:
    $ 21.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Aging is a risk factor in development of certain types of cancer. For example, breast cancer incidence increases with ageing exponentially until menopause, at which point the rate of increase slows down. With Her2-positive cancer, the entire age-dependent increase in cancer incidence is observed before menopause, i.e. in mid-age individuals. An important problem which hampers investigation of effects of aging on cancer is the lack of adequate animal models. Here, based on analyses of both population and animal studies we identify that age-related effects on tumor development can be investigated in mice using models of Her2- positive breast cancer. This pilot project is aimed to delineate a putative age-dependent factor(s) in development of Her2-positive cancer. In Aim 1, we will establish an animal model to elucidate age-related effects on development of Her2-positive cancer. For this purpose, we will utilize a transgenic mouse strain that expresses Her2 in mammary tissue in a regulated manner. Her2 will be induced in young and mid-age animals and time-course of the mammary tumor emergence and the multiplicity of tumors will be compared. Using this model, we will directly test the hypothesis that age affects the response of mammary tissue to Her2 oncogene. In Aim 2, we will address the mechanistic question about the nature of the age-related factor in tumor development. This Aim is based on our data that (1) Her2 induces the senescence-associated protein p21 both in human and mouse mammary epithelium, (2) p21 in addition to senescence can regulate epithelium mesenchymal transition (EMT) via controlling expression of the transcription factor SNAIL, and (3) in the mouse model Her2-mediated upregulation of p21 diminishes at mid-age. The latter effect was linked to inflammatory pathways. Here, we will test a hypothesis that age-dependent decline in p21 induction is an important age-related factor that promotes EMT, and eventually facilitates tumor emergence. We will directly test this hypothesis by comparing expression levels of p21, SNAIL, and the set of EMT markers in mammary tissue of Her2-expressing young and mid-age animals. Finally, we will cross Her2-expressing mice with p21 knockout animals to test the impact of p21 on the age-dependent component in development of Her2-positive cancer in the mouse model. Overall this program will both establish an adequate model to study age-dependence of Her2-positive cancer, and clarify the molecular pathway responsible for the age-dependence.
描述(由申请人提供):衰老是某些类型癌症发展的危险因素。例如,乳腺癌的发病率随着年龄的增长而增加,直到更年期为止,此时增加的速度降低了。在HER2阳性癌症的情况下,在更年期之前观察到癌症发生率的全部依赖性增加,即中年龄个体。阻碍衰老对癌症影响的一个重要问题是缺乏足够的动物模型。在这里,根据对种群和动物研究的分析,我们确定可以使用HER2-阳性乳腺癌模型研究与年龄相关的肿瘤发展作用。该试点项目的目的是描述HER2阳性癌症发展的推定年龄依赖性因素。在AIM 1中,我们将建立一个动物模型,以阐明与年龄有关HER2阳性癌症发展的影响。为此,我们将利用一种以调节方式在乳腺组织中表达HER2的转基因小鼠菌株。 HER2将在年轻和中年龄动物中诱导,并将乳腺肿瘤出现的时间顺序诱导,并将肿瘤的多样性进行比较。使用此模型,我们将直接检验一个假设,即年龄会影响乳腺组织对HER2癌基因的反应。在AIM 2中,我们将解决有关肿瘤发育中与年龄相关因素的性质的机械问题。 This Aim is based on our data that (1) Her2 induces the senescence-associated protein p21 both in human and mouse mammary epithelium, (2) p21 in addition to senescence can regulate epithelium mesenchymal transition (EMT) via controlling expression of the transcription factor SNAIL, and (3) in the mouse model Her2-mediated upregulation of p21 diminishes at mid-age.后一种效应与炎症途径有关。在这里,我们将检验一个假设,即P21诱导年龄依赖性下降是促进EMT并最终促进肿瘤出现的重要因素。我们将通过比较表达HER2的年轻和中年龄动物的乳腺组织中的p21,蜗牛和EMT标记的表达水平来直接检验这一假设。最后,我们将用P21敲除动物跨越HER2的小鼠,以测试p21对小鼠模型中HER2阳性癌症发展中依赖年龄的成分的影响。总体而言,该计划将建立一个足够的模型来研究HER2阳性癌的年龄依赖性,并阐明负责年龄依赖性的分子途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Y Sherman其他文献

Michael Y Sherman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Y Sherman', 18)}}的其他基金

Age Dependence of Breast Cancer
乳腺癌的年龄依赖性
  • 批准号:
    8668909
  • 财政年份:
    2013
  • 资助金额:
    $ 21.36万
  • 项目类别:
CHARACTERIZATION OF HUNTINGTON AND PARKINSON AGGREGATES BY MASS SPECTROMETRY
通过质谱法表征亨廷顿和帕金森聚集体
  • 批准号:
    8365536
  • 财政年份:
    2011
  • 资助金额:
    $ 21.36万
  • 项目类别:
CHARACTERIZATION OF POLYGLUTAMINE AGGREGATES BY MASS SPECTROMETRY
通过质谱法表征聚谷氨酰胺聚集体
  • 批准号:
    8170904
  • 财政年份:
    2010
  • 资助金额:
    $ 21.36万
  • 项目类别:
CHARACTERIZATION OF POLYGLUTAMINE AGGREGATES BY MASS SPECTROMETRY
通过质谱法表征聚谷氨酰胺聚集体
  • 批准号:
    7955936
  • 财政年份:
    2009
  • 资助金额:
    $ 21.36万
  • 项目类别:
Suppression of the heat shock response in aging and neurodegeneration
抑制衰老和神经退行性疾病中的热休克反应
  • 批准号:
    7512138
  • 财政年份:
    2008
  • 资助金额:
    $ 21.36万
  • 项目类别:
CHARACTERIZATION OF POLYGLUTAMINE AGGREGATES BY MASS SPECTROMETRY
通过质谱法表征聚谷氨酰胺聚集体
  • 批准号:
    7723036
  • 财政年份:
    2008
  • 资助金额:
    $ 21.36万
  • 项目类别:
Suppression of the heat shock response in aging and neurodegeneration
抑制衰老和神经退行性疾病中的热休克反应
  • 批准号:
    7668382
  • 财政年份:
    2008
  • 资助金额:
    $ 21.36万
  • 项目类别:
CHARACTERIZATION OF POLYGLUTAMINE AGGREGATES BY MASS SPECTROMETRY
通过质谱法表征聚谷氨酰胺聚集体
  • 批准号:
    7602030
  • 财政年份:
    2007
  • 资助金额:
    $ 21.36万
  • 项目类别:
Cellular Mechanisms of Aggregation of Abnormal Proteins
异常蛋白质聚集的细胞机制
  • 批准号:
    8034757
  • 财政年份:
    2004
  • 资助金额:
    $ 21.36万
  • 项目类别:
Cell Mechanisms of Abnormal Protein Aggregation
蛋白质异常聚集的细胞机制
  • 批准号:
    7098014
  • 财政年份:
    2004
  • 资助金额:
    $ 21.36万
  • 项目类别:

相似国自然基金

多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
  • 批准号:
    82373667
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
  • 批准号:
    12303035
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
  • 批准号:
    12301629
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
  • 批准号:
    82304205
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
  • 批准号:
    42305193
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
  • 批准号:
    10751106
  • 财政年份:
    2024
  • 资助金额:
    $ 21.36万
  • 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
  • 财政年份:
    2024
  • 资助金额:
    $ 21.36万
  • 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
  • 批准号:
    10462257
  • 财政年份:
    2023
  • 资助金额:
    $ 21.36万
  • 项目类别:
Genetics of Extreme Phenotypes of OSA and Associated Upper Airway Anatomy
OSA 极端表型的遗传学及相关上呼吸道解剖学
  • 批准号:
    10555809
  • 财政年份:
    2023
  • 资助金额:
    $ 21.36万
  • 项目类别:
Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach
识别和解决社交媒体使用对年轻人电子烟使用的影响:面向解决方案的方法
  • 批准号:
    10525098
  • 财政年份:
    2023
  • 资助金额:
    $ 21.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了